The jeuveau market research report is one of a series of new reports that provides jeuveau market statistics, including the jeuveau industry global market size, regional shares, competitors with the jeuveau market share, detailed jeuveau market segments, market trends, and opportunities, and any further data you may need to thrive in the jeuveau industry. This jeuveau market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The growth in the forecast period can be attributed to increasing demand for injectable aesthetic procedures, growing R&D initiatives, growing patient preference for non-invasive treatments, increasing clinical trial volumes, and increased prevalence of various disorders. Major trends in the forecast period include technological advancements, research initiatives, advancements in botulinum toxin formulations, shifting towards minimally invasive procedures, and technological advancements in delivery systems.
The growing demand for cosmetic procedures is expected to significantly drive the expansion of the jeuveau market. Cosmetic procedures, which are medical treatments aimed at enhancing or altering one's appearance for aesthetic purposes, are gaining popularity due to the influence of social media, increased focus on self-care, and advancements in non-invasive technologies that offer safer, more affordable options. Jeuveau, a botulinum toxin injectable, is commonly used in these procedures to temporarily reduce facial wrinkles, especially frown lines between the eyebrows, by relaxing targeted muscles and smoothing the skin. For example, according to the British Association of Aesthetic Plastic Surgeons, in March 2023, the number of cosmetic procedures surged by 102% in 2022, reaching 31,057 procedures compared to the previous year. This rising demand for cosmetic treatments is expected to fuel the growth of the jeuveau market.
A notable trend in the jeuveau market is the increasing adoption of subscription models, such as monthly memberships, to improve customer retention, provide more affordable access to treatments, and promote steady revenue growth. These subscription-based services allow customers to pay a fixed monthly fee for ongoing access to treatments at a discounted rate. For instance, in November 2024, Evolus, the U.S.-based manufacturer of Jeuveau, introduced its Club Evolus membership. This program offers consumers a subscription for $49 per month, providing 20 units of Jeuveau every 90 days. With an average cost of $13 per unit, members save approximately $113 per treatment. By 2024, 100 practices had enrolled in the program, with plans for expansion in 2025.
In December 2022, Pipeline Medical, a U.S.-based MedTech marketplace, formed a partnership with Evolus Inc. to improve access to Jeuveau in aesthetic practices. The partnership aims to streamline distribution, enabling plastic surgeons, dermatologists, and medical spas to directly source Jeuveau. This expanded network is expected to support wider adoption among healthcare professionals specializing in aesthetic treatments. Evolus Inc. is the U.S.-based company that manufactures jeuveau.
The key company operating in the jeuveau market is Evolus Inc.
North America was the largest region in the jeuveau market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in jeuveau report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the jeuveau market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Jeuveau is a prescription injectable treatment containing botulinum toxin type A, used to temporarily improve the appearance of moderate to severe glabellar lines (frown lines) between the eyebrows. It is an alternative to Botox, offering similar results with minimal recovery time.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary clinical indications for jeuveau are glabellar lines and other related conditions. Glabellar lines are the vertical wrinkles or creases that form between the eyebrows, commonly known as frown lines. The patient demographics for Jeuveau include millennial patients, Generation X, older adults, and both genders. It has various applications, including both therapeutic and aesthetic uses. The main end users of Jeuveau include dermatology centers, hospitals and clinics, and other medical facilities.
The jeuveau market consists of sales of botulinum toxin injections, combination treatment packages, accessories, and support products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values are revenues generated by organizations in the specified geography within the market irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The growth in the forecast period can be attributed to increasing demand for injectable aesthetic procedures, growing R&D initiatives, growing patient preference for non-invasive treatments, increasing clinical trial volumes, and increased prevalence of various disorders. Major trends in the forecast period include technological advancements, research initiatives, advancements in botulinum toxin formulations, shifting towards minimally invasive procedures, and technological advancements in delivery systems.
The growing demand for cosmetic procedures is expected to significantly drive the expansion of the jeuveau market. Cosmetic procedures, which are medical treatments aimed at enhancing or altering one's appearance for aesthetic purposes, are gaining popularity due to the influence of social media, increased focus on self-care, and advancements in non-invasive technologies that offer safer, more affordable options. Jeuveau, a botulinum toxin injectable, is commonly used in these procedures to temporarily reduce facial wrinkles, especially frown lines between the eyebrows, by relaxing targeted muscles and smoothing the skin. For example, according to the British Association of Aesthetic Plastic Surgeons, in March 2023, the number of cosmetic procedures surged by 102% in 2022, reaching 31,057 procedures compared to the previous year. This rising demand for cosmetic treatments is expected to fuel the growth of the jeuveau market.
A notable trend in the jeuveau market is the increasing adoption of subscription models, such as monthly memberships, to improve customer retention, provide more affordable access to treatments, and promote steady revenue growth. These subscription-based services allow customers to pay a fixed monthly fee for ongoing access to treatments at a discounted rate. For instance, in November 2024, Evolus, the U.S.-based manufacturer of Jeuveau, introduced its Club Evolus membership. This program offers consumers a subscription for $49 per month, providing 20 units of Jeuveau every 90 days. With an average cost of $13 per unit, members save approximately $113 per treatment. By 2024, 100 practices had enrolled in the program, with plans for expansion in 2025.
In December 2022, Pipeline Medical, a U.S.-based MedTech marketplace, formed a partnership with Evolus Inc. to improve access to Jeuveau in aesthetic practices. The partnership aims to streamline distribution, enabling plastic surgeons, dermatologists, and medical spas to directly source Jeuveau. This expanded network is expected to support wider adoption among healthcare professionals specializing in aesthetic treatments. Evolus Inc. is the U.S.-based company that manufactures jeuveau.
The key company operating in the jeuveau market is Evolus Inc.
North America was the largest region in the jeuveau market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in jeuveau report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the jeuveau market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Jeuveau is a prescription injectable treatment containing botulinum toxin type A, used to temporarily improve the appearance of moderate to severe glabellar lines (frown lines) between the eyebrows. It is an alternative to Botox, offering similar results with minimal recovery time.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary clinical indications for jeuveau are glabellar lines and other related conditions. Glabellar lines are the vertical wrinkles or creases that form between the eyebrows, commonly known as frown lines. The patient demographics for Jeuveau include millennial patients, Generation X, older adults, and both genders. It has various applications, including both therapeutic and aesthetic uses. The main end users of Jeuveau include dermatology centers, hospitals and clinics, and other medical facilities.
The jeuveau market consists of sales of botulinum toxin injections, combination treatment packages, accessories, and support products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values are revenues generated by organizations in the specified geography within the market irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Jeuveau Market Characteristics4. Jeuveau Market Trends And Strategies5. Jeuveau Market -Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market7. Global Jeuveau Pricing Analysis & Forecasts30. Global Jeuveau Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Jeuveau Market32. Recent Developments In The Jeuveau Market
3. Jeuveau Market Biologic Drug Characteristics
6. Global Jeuveau Growth Analysis And Strategic Analysis Framework
8. Jeuveau Market Segmentation
9. Global Jeuveau Epidemiology Of Clinical Indications
10. Jeuveau Market Regional And Country Analysis
11. Asia-Pacific Jeuveau Market
12. China Jeuveau Market
13. India Jeuveau Market
14. Japan Jeuveau Market
15. Australia Jeuveau Market
16. South Korea Jeuveau Market
17. Western Europe Jeuveau Market
18. UK Jeuveau Market
19. Germany Jeuveau Market
20. France Jeuveau Market
21. Eastern Europe Jeuveau Market
22. North America Jeuveau Market
23. USA Jeuveau Market
24. Canada Jeuveau Market
25. South America Jeuveau Market
26. Middle East Jeuveau Market
27. Africa Jeuveau Market
28. Jeuveau Market Competitive Landscape And Company Profiles
29. Global Jeuveau Market Pipeline Analysis
33. Jeuveau Market High Potential Countries, Segments and Strategies
34. Appendix
Executive Summary
Jeuveau Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on jeuveau market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for jeuveau ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The jeuveau market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Clinical Indication: Glabellar Lines; Other Indications2) By Patient Demographics: Millennial Patients; Gen X and Older Adults; Gender Segmentation
3) By Application: Therapeutic; Aesthetic
4) By End User: Dermatology Centres; Hospitals and clinics; Other End Users
Key Companies Profiled: Evolus Inc.
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Evolus Inc.
